12/20/2024 7:00 AM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2024 3:01 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024 7:15 AM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 3:19 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 424B4 | |
09/17/2024 11:15 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form EFFECT | |
09/16/2024 12:55 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form F-1/A | |
09/16/2024 8:29 AM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form F-1/A | |
|
08/22/2024 3:53 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
07/14/2024 11:15 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form EFFECT | |
07/08/2024 4:17 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form POS AM | |
07/01/2024 6:08 AM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 20-F/A | |
04/22/2024 3:31 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 20-F/A | |
04/17/2024 11:15 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form EFFECT | |
04/17/2024 3:20 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 424B4 | |
04/16/2024 4:00 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024 7:30 AM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024 7:30 AM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024 7:00 AM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
04/10/2024 7:15 AM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
04/10/2024 7:15 AM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024 10:03 AM | Altamira Therapeutics Ltd. (Subject) Altamira Therapeutics (Subject) Meyer Thomas (Filed by)
| Form SC 13D/A | |
01/22/2024 4:02 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 424B4 | |
01/21/2024 11:15 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form EFFECT | |
01/19/2024 3:40 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 424B5 | |
01/19/2024 3:45 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/19/2024 3:30 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 4:02 PM | Altamira Therapeutics Ltd. (Filer) Altamira Therapeutics (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |